Clinical trials
Phase 3 Myelodysplastic Syndromes trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 3 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Gamida Cell ltd | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Institut de Recherches Internationales Servier | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 11 |
| Anemia | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Lymphoma | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.